Allsopp T E, McLuckie J, Kerr L E, Macleod M, Sharkey J, Kelly J S. 2000. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death and Differentiation, 7, 984–993.
Bertzbach L D, van Haarlem D A, Hartle S, Kaufer B B, Jansen C A. 2019a. Marek’s disease virus infection of natural killer cells. Microorganisms, 7, 588.
Bertzbach L D, Harlin O, Hartle S, Fehler F, Vychodil T, Kaufer B B, Kaspers B. 2019b. IFNα and IFNγ impede Marek’s disease progression. Viruses, 11, 1103.
Bertzbach L D, Kheimar A, Ali F A Z, Kaufer B B. 2018. Viral factors involved in Marek’s disease virus (MDV) pathogenesis. Current Clinical Microbiology Reports, 5, 238–244.
Biggs P M. 1997. The leeuwenhoek lecture, 1997. Marek’s disease herpesvirus: Oncogenesis and prevention. Philosophical Transactions of the Royal Society of London (Series B: Biological Sciences), 352, 1951–1962.
Boodhoo N, Gurung A, Sharif S, Behboudi S. 2016. Marek’s disease in chickens: A review with focus on immunology. Veterinary Research, 47, 119.
Brown A C, Baigent S J, Smith L P, Chattoo J P, Petherbridge L J, Hawes P, Allday M J, Nair V. 2006. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek’s disease virus. Proceedings of the National Academy of Sciences of the United States of America, 103, 1687–1692.
Deng X, Li X, Shen Y, Qiu Y, Shi Z, Shao D, Jin Y, Chen H, Ding C, Li L, Chen P, Ma Z. 2010. The Meq oncoprotein of Marek’s disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities. Virology Journal, 7, 348.
Dong D, Gao J, Sun Y, Long Y, Li M, Zhang D, Gong J, Xu L, Li L, Qin S, Ma J, Jin T. 2015. Adenovirus-mediated co-expression of the TRAIL and HN genes inhibits growth and induces apoptosis in Marek’s disease tumor cell line MSB-1. Cancer Cell International, 15, 20.
Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B, Zhu Z. 2010. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Letters, 298, 50–63.
Haertle S, Alzuheir I, Busalt F, Waters V, Kaiser P, Kaufer B B. 2017. Identification of the receptor and cellular ortholog of the Marek’s disease virus (MDV) CXC chemokine. Frontiers in Microbiology, 8, 2543.
Heidari M, Zhang H M, Sharif S. 2008. Marek’s disease virus induces Th-2 activity during cytolytic infection. Viral Immunology, 21, 203–214.
Kung H J, Xia L, Brunovskis P, Li D, Liu J L, Lee L F. 2001. Meq: An MDV-specific bZIP transactivator with transforming properties. Current Topics in Microbiology and Immunology, 255, 245–260.
Levy A M, Gilad O, Xia L, Izumiya Y, Choi J, Tsalenko A, Yakhini Z, Witter R, Lee L, Cardona C J, Kung H J. 2005. Marek’s disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: A converging transforming pathway for avian oncoviruses. Proceedings of the National Academy of Sciences of the United States of America, 102, 14831–14836.
Li H, Zhu J, He M, Luo Q, Liu F, Chen R. 2018. Marek’s disease virus activates the PI3K/Akt pathway through interaction of its protein Meq with the p85 subunit of PI3K to promote viral replication. Frontiers in Microbiology, 9, 2547.
Li X, Chiang H I, Zhu J, Dowd S E, Zhou H. 2008. Characterization of a newly developed chicken 44K Agilent microarray. BMC Genomics, 9, 1.
Lian X, Bao C, Li X, Zhang X, Chen H, Jung Y S, Qian Y. 2019. Marek’s disease virus disables the ATR-Chk1 pathway by activating STAT3. Journal of Virology, 93, e02290–e02308.
Liu J L, Ye Y, Lee L F, Kung H J. 1998. Transforming potential of the herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis. Journal of Virology, 72, 388–395.
Liu J L, Ye Y, Qian Z, Qian Y, Templeton D J, Lee L F, Kung H J. 1999. Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2. Journal of Virology, 73, 4208–4219.
Loison F, Zhu H, Karatepe K, Kasorn A, Liu P, Ye K, Zhou J, Cao S, Gong H, Jenne D E, Remold-O’Donnell E, Xu Y, Luo H R. 2014. Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation. The Journal of Clinical Investigation, 124, 4445–4458.
Nair V. 2018. Spotlight on avian pathology: Marek’s disease. Avian Pathology, 47, 440–442.
Neerukonda S N, Katneni U K, Bott M, Golovan S P, Parcells M S. 2018. Induction of the unfolded protein response (UPR) during Marek’s disease virus (MDV) infection. Virology, 522, 1–12.
Padhi A, Parcells M S. 2016. Positive selection drives rapid evolution of the meq oncogene of Marek’s disease virus. PLoS ONE, 11, e0162180.
Subramaniam S, Johnston J, Preeyanon L, Brown C T, Kung H J, Cheng H H. 2013. Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek’s disease virus oncoprotein, Meq. Journal of Virology, 87, 9016–9029.
Sun J, Hemler M E. 2001. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Research, 61, 2276–2281.
Tabouret E, Boudouresque F, Farina P, Barrie M, Bequet C, Sanson M, Chinot O. 2015. MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma. Neuro-Oncology, 17, 1174–1176.
Tai S S, Hearn C, Umthong S, Agafitei O, Cheng H H, Dunn J R, Niikura M. 2017. Expression of Marek’s disease virus oncoprotein Meq during infection in the natural host. Virology, 503, 103–113.
Teng M, Yu Z H, Zhao P, Zhuang G Q, Wu Z X, Dang L, Li H Z, Ma S M, Cui Z Z, Zhang G P, Wu R, Luo J. 2017. Putative roles as oncogene or tumour suppressor of the Mid-clustered microRNAs in Gallid alphaherpesvirus 2 (GaHV2) induced Marek’s disease lymphomagenesis. The Journal of General Virology, 98, 1097–1112.
Xie Q, Anderson A S, Morgan R W. 1996. Marek’s disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. Journal of Virology, 70, 1125–1131.
Yao Y, Nair V. 2014. Role of virus-encoded microRNAs in avian viral diseases. Viruses, 6, 1379–1394.
Yao Y, Zhao Y, Xu H, Smith L P, Lawrie C H, Watson M, Nair V. 2008. MicroRNA profile of Marek’s disease virus-transformed T-cell line MSB-1: Predominance of virus-encoded microRNAs. Journal of Virology, 82, 4007–4015.
Zhang Y, Luo J, Tang N, Teng M, Reddy V, Moffat K, Shen Z, Nair V, Yao Y. 2019. Targeted editing of the pp38 gene in Marek’s disease virus-transformed cell lines using CRISPR/Cas9 system. Viruses, 11, 391.
|